Max Robotics — Global Service Robot Directory + US Certification

About

D. Crotzer is a gynecologic oncologist whose research focuses on de-escalating treatment for early-stage cervical cancer to reduce morbidity without compromising oncologic outcomes. Their most notable contribution is the landmark "23 Concerv" prospective trial, which evaluated conservative surgery—specifically, simple hysterectomy or cone biopsy with pelvic lymph node dissection—for low-risk, early-stage cervical cancer. This work, cited 15 times, challenged the traditional radical hysterectomy paradigm, demonstrating that less extensive surgery can be safe for carefully selected patients, thereby preserving fertility and quality of life. Crotzer’s research has directly influenced clinical guidelines, offering a personalized, less invasive approach for women with small tumors and no lymph node involvement. By prioritizing patient-centered outcomes and surgical innovation, Crotzer has advanced the field of gynecologic oncology, providing evidence that supports a shift toward more conservative management. Their work continues to shape discussions on risk stratification and the balance between cancer control and functional preservation, making a lasting impact on the care of women with cervical cancer.